Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
Stopped Withdrawn due to COVID-19 related clinical limitations
Conditions
- Diabetes Mellitus, Type 1
Interventions
- DRUG: Golimumab
- DRUG: Placebo
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborators